Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Travere Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TVTX.
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Other companies in Travere Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG), Arcutis Biotherapeutics (NASDAQ:ARQT) and Mesoblast (NASDAQ:MESO).
Travere Therapeutics has a consensus price target of $30.58.
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $20.265 last updated March 17, 2025 at 10:39 AM EDT.
There are no upcoming dividends for Travere Therapeutics.
Travere Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for Travere Therapeutics.
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.